Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma (Q37641646)
Jump to navigation
Jump to search
scientific article published on 19 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma |
scientific article published on 19 September 2013 |
Statements
1 reference
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma (English)
1 reference
1 reference
Meenhard Herlyn
1 reference
Adina Vultur
1 reference
Clemens Krepler
1 reference
Giorgos C Karakousis
1 reference
Katrin Sproesser
1 reference
Rolf K Swoboda
1 reference
Minu Samanta
1 reference
Jessie Villanueva
1 reference
Jeffrey R Infante
1 reference
Patricia Reyes-Uribe
1 reference
Hsin-Yi Chen
1 reference
Bin Li
1 reference
Mizuho Fukunaba-Kalabis
1 reference
Bradley Wubbenhorst
1 reference
Thomas Y Chen
1 reference
Qin Liu
1 reference
Douglas J DeMarini
1 reference
Tona M Gilmer
1 reference
Anne-Marie Martin
1 reference
Ronen Marmorstein
1 reference
David C Schultz
1 reference
David W Speicher
1 reference
Wei Xu
1 reference
Ravi K Amaravadi
1 reference
Xiaowei Xu
1 reference
Lynn M Schuchter
1 reference
19 September 2013
1 reference
Identifiers
1 reference